Efficacy and Safety of HAT1 Compared to Calcipotriol in Patients With Mild to Moderate Chronic Plaque Psoriasis

Condition:   Psoriasis Interventions:   Drug: HAT1;   Drug: Calcipotriol Sponsor:   Haus Bioceuticals Completed

Source: ClinicalTrials.gov - February 21, 2019 Category: Research Source Type: clinical trials